Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for PHCUF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2026 80.69M
December 31, 2025 70.05M
September 30, 2025 69.82M
June 30, 2025 67.73M
March 31, 2025 67.26M
December 31, 2024 65.08M
September 30, 2024 68.40M
June 30, 2024 67.02M
March 31, 2024 65.87M
December 31, 2023 70.11M
September 30, 2023 66.31M
June 30, 2023 65.95M
March 31, 2023 67.41M
December 31, 2022 72.99M
September 30, 2022 67.23M
June 30, 2022 74.29M
March 31, 2022 84.41M
December 31, 2021 89.55M
September 30, 2021 89.34M
June 30, 2021 90.32M
March 31, 2021 89.84M
December 31, 2020 90.64M
September 30, 2020 65.02M
June 30, 2020 63.47M
March 31, 2020 22.85M
Date Value
December 31, 2019 29.29M
September 30, 2019 23.84M
June 30, 2019 25.92M
March 31, 2019 26.99M
December 31, 2018 26.70M
September 30, 2018 28.06M
June 30, 2018 29.37M
March 31, 2018 31.88M
December 31, 2017 32.17M
September 30, 2017 32.61M
June 30, 2017 32.23M
March 31, 2017 32.38M
December 31, 2016 33.21M
September 30, 2016 32.20M
June 30, 2016 31.31M
March 31, 2016 30.16M
December 31, 2015 28.02M
September 30, 2015 29.24M
June 30, 2015 31.72M
March 31, 2015 32.29M
December 31, 2014 36.09M
September 30, 2014 47.50M
June 30, 2014 46.28M
March 31, 2014 50.12M
December 31, 2013 49.73M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 114.02B
ANI Pharmaceuticals, Inc. 1.422B
Corcept Therapeutics, Inc. 814.88M
Assertio Holdings, Inc. 211.30M
Veru, Inc. 43.08M

Total Assets (Quarterly) Related Metrics